We are live on ! Find out more
DCI

Data Collective IV Portfolio holdings

AUM $55.9M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+49.14%
3 Year Est. Return
+250.98%
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
+$5.41M
Cap. Flow
+$13.5M
Cap. Flow %
10.66%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
DFTX
Definium Therapeutics
DFTX
+$13.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 54.1%
2 Industrials 27.19%
3 Technology 18.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.62B
$63.2M 49.97%
5,941,120
EMBK
2
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$23.7M 18.71%
3,186,008
EVLV icon
3
Evolv Technologies
EVLV
$1.01B
$22.5M 17.77%
10,601,281
RKLB icon
4
Rocket Lab Corp
RKLB
$39.9B
$11.9M 9.42%
2,929,350
DFTX
5
Definium Therapeutics
DFTX
$5.57B
$5.22M 4.13%
1,505,248
+1,404,898
+1,400% +$13.5M

Similar funds

Data Collective IV's Q3 2022 Portfolio in Review

As of Q3 2022, Data Collective IV held 5 positions worth $127M, up 4.5% from $121M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Data Collective IV deployed $13.5M of net new capital in Q3 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 41% a quarter earlier, followed by Industrials and Technology.

  • Data Collective IV added most to Definium Therapeutics in Q3 2022, an estimated $13.5M increase.
  • Data Collective IV's ten largest holdings make up 100% of its $127M portfolio in Q3 2022.
  • Data Collective IV opened 0 new positions and closed 0 in Q3 2022.
  • Data Collective IV's portfolio value rose 4.5% quarter-over-quarter to $127M.

Based on Data Collective IV's 13F filing for Q3 2022, filed 14 Nov 2022.